SAR of Bromodomain Inhibitor/Linker for Modulation of Release Profile of BET-BRUSH Prodrugs

Exclusively Licensed

The present disclosure provides, in some aspects, macromonomers of Formula (I), and salts thereof; methods of preparing the macromonomers, and salts thereof; Brush prodrugs (polymers); methods of preparing the Brush prodrugs; compounds of Formula (II); conjugates of Formula (III), and salts thereof; pharmaceutical compositions comprising a Brush prodrug, or a conjugate or a salt thereof; kits comprising: a macromonomer or a salt thereof, a Brush prodrug, a compound, a conjugate or a salt thereof, or a pharmaceutical composition; methods of using the Brush prodrugs, or conjugates or salts thereof; and uses of the Brush prodrugs, and conjugates or salts thereof. These chemical entities may be useful in delivering pharmaceutical agents to a subject or cell.

Researchers

Jeremiah A. Johnson / Farrukh Vohidov

Departments: Department of Chemistry
Technology Areas: Therapeutics: Small Molecules
Impact Areas: Healthy Living

  • brush prodrugs and uses thereof
    Canada | Published application
  • brush prodrugs and uses thereof
    United States of America | Pending
  • brush prodrugs and uses thereof
    European Patent Convention | Published application
  • brush prodrugs and uses thereof
    United States of America | Granted | 12,414,997

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.